Fund family: ARIEL INVESTMENT TRUST · Filed by ARIEL INVESTMENT TRUST (CIK 798365) · SEC series S000005024
Share classes and tickers: ARAIX (C000108536), ARGFX (C000013706)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 325 with, 4 against, 0 abstentions (not counted as with management). Shareholder proposals: 0 FOR, 4 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other ARIEL INVESTMENT TRUST funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.
The same votes as “with management” above, by the sector of the company voted on. 93.6% of this fund’s 329 such votes could be given a sector; the other 21 (6.4%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 107 | 2 | 1.9% |
| Finance | 94 | 0 | 0.0% |
| Health Care | 40 | 0 | 0.0% |
| Industrials | 40 | 2 | 5.0% |
| Real Estate | 12 | 0 | 0.0% |
| Consumer Staples | 11 | 0 | 0.0% |
| Energy | 4 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 242 | 0 |
| Say-on-Pay | 34 | 0 |
| Audit-related | 32 | 0 |
| Compensation | 14 | 0 |
| Corporate Governance | 5 | 2 |
| Shareholder Rights and Defenses | 4 | 2 |
| Capital Structure | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Madison Square Garden Entertainment Corp. | December 10, 2025 | $254M | 5 | 0 |
| Charles River Laboratories International, Inc. | May 5, 2026 | $162M | 15 | 0 |
| Affiliated Managers Group, Inc. | May 27, 2026 | $130M | 9 | 0 |
| Mohawk Industries, Inc. | May 21, 2026 | $122M | 7 | 1 |
| Zebra Technologies Corporation | May 19, 2026 | $120M | 7 | 0 |
| Bio-Rad Laboratories, Inc. | April 21, 2026 | $111M | 6 | 1 |
| Jones Lang LaSalle Incorporated | May 28, 2026 | $105M | 14 | 0 |
| Envista Holdings Corporation | May 19, 2026 | $104M | 11 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 21, 2026 | Mohawk Industries, Inc. | Stockholder proposal regarding a majority vote standard. Shareholder proposal | Against | For |
| April 21, 2026 | Bio-Rad Laboratories, Inc. | Stockholder proposal regarding dual class capital structure. Shareholder proposal | Against | For |
| June 3, 2026 | Resideo Technologies, Inc. | Shareholder Proposal Regarding Shareholder Right to Act by Written Consent. Shareholder proposal | Against | For |
| June 11, 2026 | Norwegian Cruise Line Holdings Ltd. | A shareholder proposal requesting the declassification of our board of directors, if properly presented Shareholder proposal | Against | For |
332 ballot items at 34 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Ariel Fund (ARAIX) voted at 34 shareholder meetings of 33 companies, on 332 ballot items in all. Where management made a recommendation, the fund followed it on 98.8% of the items and voted against it 4 times. Its most frequent area of disagreement was corporate governance (2 of its votes against management). It voted on 4 shareholder proposals.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.